MaxCyte, Inc. (MXCT)
NASDAQ · Healthcare
MaxCyte, Inc. Net Income 2019–2025
MaxCyte, Inc. annual/quarterly net income history and growth rate from 2019 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- MaxCyte, Inc. net income for the quarter ending March 31, 2026 was -4.8 M, a 53.71% decrease year-over-year.
- MaxCyte, Inc. net income for the twelve months ending March 31, 2026 was -39.8 M, a 4.62% decrease year-over-year.
- MaxCyte, Inc. annual net income for 2025 was -44.6 M, a 8.71% increase from 2024.
- MaxCyte, Inc. annual net income for 2024 was -41.1 M, a 8.26% increase from 2023.
- MaxCyte, Inc. annual net income for 2023 was -37.9 M, a 60.89% increase from 2022.
- MaxCyte, Inc. annual net income for 2022 was -23.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
MaxCyte, Inc. Net Income — FAQ
MaxCyte, Inc. (MXCT) net income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is MaxCyte, Inc.'s net income?
MaxCyte, Inc. (MXCT) reported net income of -$45M for fiscal 2025.
Where can I see MXCT's net income history?
The chart and table above show MaxCyte, Inc.'s net income by year and by quarter, including the growth rate.